Patient and prescriber views of penicillin-allergy testing and subsequent antibiotic use: a rapid review by Wanat, M et al.
antibiotics
Review
Patient and Prescriber Views of Penicillin Allergy
Testing and Subsequent Antibiotic Use:
A Rapid Review
Marta Wanat 1,*, Sibyl Anthierens 2, Christopher C. Butler 1, Judy M. Wright 3 ID ,
Naila Dracup 3 ID , Sue H. Pavitt 4, Jonathan A. T. Sandoe 5 and Sarah Tonkin-Crine 1,6 ID
1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter,
Woodstock Road, Oxford OX2 6GG, UK; christopher.butler@phc.ox.ac.uk (C.C.B.);
sarah.tonkin-crine@ndm.ox.ac.uk (S.T.-C.)
2 Department of Primary and Interdisciplinary care, University of Antwerp, Campus “Drie Eiken”, Gebouw
R, Universiteitsplein 1, B-2610 WILRIJK Antwerpen, Belgium; Sibyl.Anthierens@uantwerpen.be
3 Leeds Institute of Health Sciences’, Faculty of Medicine and Health, University of Leeds, Worsley Building,
Clarendon Way, Leeds LS2 9LU, UK; J.M.Wright@leeds.ac.uk (J.M.W.); N.Dracup@leeds.ac.uk (N.D.)
4 Dental Translational and Clinical Research Unit, Faculty of Medicine and Health, University of Leeds,
Worsley Building, Clarendon Way, Leeds LS2 9LU, UK; S.Pavitt@leeds.ac.uk
5 Healthcare Associated Infection Group, University of Leeds and Leeds Teaching Hospitals NHS Trust,
Leeds LS13EX, UK; J.Sandoe@leeds.ac.uk
6 NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance,
University of Oxford, Wellington Square, Oxford OX1 2JD, UK
* Correspondence: marta.wanat@phc.ox.ac.uk; Tel.: +44-1865-617-935
Received: 21 June 2018; Accepted: 31 July 2018; Published: 6 August 2018


Abstract: About 10% of U.K. patients believe that they are allergic to penicillin and have
a “penicillin allergy label” in their primary care health record. However, around 90% of these patients
may be mislabelled. Removing incorrect penicillin allergy labels can help to reduce unnecessary
broad-spectrum antibiotic use. A rapid review was undertaken of papers exploring patient and/or
clinician views and experiences of penicillin allergy testing (PAT) services and the influences on
antibiotic prescribing behaviour in the context of penicillin allergy. We reviewed English-language
publications published up to November 2017. Limited evidence on patients’ experiences of PAT
highlighted advantages to testing as well as a number of concerns. Clinicians reported uncertainty
about referral criteria for PAT. Following PAT and a negative result, a number of clinicians and
patients remained reluctant to prescribe and consume penicillins. This appeared to reflect a lack of
confidence in the test result and fear of subsequent reactions to penicillins. The findings suggest
lack of awareness and knowledge of PAT services by both clinicians and patients. In order to ensure
correct penicillin allergy diagnosis, clinicians and patients need to be supported to use PAT services
and equipped with the skills to use penicillins appropriately following a negative allergy test result.
Keywords: penicillin allergy; antibiotic stewardship; prescribing; antibiotic resistance
1. Introduction
Prescribing the most appropriate antibiotic class, the narrowest effective spectrum, duration,
and dose will help to improve patient outcomes whilst reducing development of antibiotic resistance.
Allergies to antibiotics influence prescribing decisions, sometimes preventing treatment with
“first-line” antibiotics.
Penicillins are generally safe, effective, and narrow-spectrum and, as a result, are the first-line
recommended treatment for many infections. However, about 10% of patients in the U.K. believe
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that they are allergic to penicillin and have a “penicillin allergy label” in primary care electronic
health records [1]. Case series exploring the basis for these allergy labels reveal that only 10% of these
people are likely to be truly allergic to penicillins [2]. As a result, these patients are usually prescribed
alternative broad-spectrum antibiotics unnecessarily, which contributes to increased antimicrobial
resistance. Non-penicillin antibiotics may be less effective treatments and carry additional long-term
health risks [3]. Patients who are mislabeled with an allergy to penicillin can be readily identified
using a combination of medical history, skin testing, and oral challenge [4]; this approach offers greater
specificity than each element alone [5]. The combination of negative skin testing and negative oral
challenge testing has been found to have >99% negative predictive value for penicillin allergy [6].
De-labelling has been found to be cost effective and safe in both children and adult populations [7,8].
The National Institute for Health and Care Excellence (NICE) has highlighted the importance of
PAT and proposed criteria for selecting patients for testing [1]. Referral to, and use of, PAT services is
not currently common practice in U.K. general practice and there is an unmet need for PAT services.
Greater use of these services would help identify patients with incorrect allergy labels, provide access
to a wider variety of antibiotic treatments for these patients, and potentially contribute to a reduction
in prescribing of broad-spectrum antibiotics. In order to encourage use and expansion of such services
the views and experiences of patients and clinicians need to be better understood to identify barriers
and enablers to use.
A rapid review was undertaken to identify studies exploring patients’ and/or clinicians’ views
and experiences of penicillin allergy testing (PAT) services and/or to explore the influences on antibiotic
prescribing behaviour in the context of penicillin allergy. Rapid review is a form of synthesis to support
review of existing evidence in a timely manner. It is particularly useful in healthcare where there is
an increasing demand for a timely access to new evidence, especially for policymakers, healthcare
professionals, and healthcare institutions [9,10]. Rapid reviews differ from systematic reviews in that
they tend to have more targeted research questions; they often include limited sources with language
and time restrictions, or use only one reviewer when selecting and extracting data [11].
2. Materials and Methods
We searched Applied Social Sciences Index and Abstracts (ASSIA) (ProQuest) 1987–present;
the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO) 1981–present;
Cochrane Central Register of Controlled Trials: Issue 10 of 12, October 2017 and Issue 11 of
12, November 2017; Cochrane Database of Systematic Reviews: Issue 10 of 12, October 2017
and Issue 11 of 12, November 2017; Database of Abstracts of Reviews of Effect: Issue 2 of 4,
April 2015; Cochrane Methodology Register: Issue 3 of 4, July 2012; NHS Economic Evaluation
Database: Issue 2 of 4, April 2015; Health Technology Assessment Database: Issue 4 of 4, October 2016;
Embase Classic + Embase 1947 to 11 October 2017, Ovid MEDLINE(R) 1946 to November Week 1 2017,
Ovid MEDLINE(R) Epub Ahead of Print 9 November 2017, Ovid MEDLINE(R) In-Process & Other
Non-Indexed Citations 9 November 2017, PsycINFO 1806 to October Week 1 2017, PubMed (NLM)
1946—present, and Web of Science-Clarivate Analytics core collection. We searched for studies that
described either (a) patient or clinician views and experiences of (diagnosing) penicillin allergy or
testing for penicillin allergy or (b) influences on clinicians’ antibiotic prescribing behaviour in the
context of penicillin allergy. Search strategies were developed for each database in collaboration
with experienced information scientists (Supplementary Materials). In order to avoid missing
potentially relevant studies, search strategies included terms related to “drug allergy” as well as
“penicillin allergy”. Key search terms included penicillin allergy; penicillin testing; clinician/patient
attitudes and experiences; drug prescribing; qualitative studies; drug allergy; and drug testing.
Subject headings and free text words were identified for use in the search concepts by text analysis
tools and project team members. Further terms were identified from relevant papers.
To be included in the review, papers had to focus on penicillin allergy (testing), explore the views
of patients or clinicians (prescribers), and use qualitative or survey methods. One reviewer screened all
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abstracts against the inclusion criteria, with another screening 10% of the abstracts. This was followed
by one reviewer screening the full texts of potentially eligible papers and extracting data from those
that were eligible. Both reviewers agreed upon the final set of studies included. We examined the
reference lists of all potentially relevant papers to identify any additional studies. We included all
relevant papers which had an abstract written in English regardless of publication type.
3. Results
A total of 8144 papers were identified. Twenty-one articles were included in the final synthesis
(Figure 1). Studies included participants from 10 countries, with 2 of the 21 studies set in the U.K.
Ten studies investigated patients’ views, nine investigated clinicians’ views, while two focused on both
patients’ and clinicians’ views. Two studies focused on the views of primary care clinicians, and nine
on professionals working in secondary care. All of the studies used a cross-sectional survey design.
An overview of the included studies is presented in Table 1.
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Table 1. Overview of the included studies.
Authors Title Country, Setting Year Design Research Aim Population
Al-Ahmad, M. &
Rodriguez-Bouza, T. [12]
Drug allergy evaluation for beta-lactam
hypersensitivity: Cross-reactivity with
cephalosporins, carbapenems, and negative
predictive value
Kuwait, tertiary
public allergy centre 2017 Telephone survey
To evaluate subsequent beta-lactam
use following a negative test
40 patients who had a negative
penicillin allergy test
Amin, W., et al. [13]
[Conference abstract]
A clinical audit on reporting and
documentation of penicillin allergy at an NHS
Foundation Trust Hospital
U.K., general hospital 2010 Questionnaire
To examine patients’ and
professionals’ perceptions and
knowledge regarding penicillin
allergic reactions
30 hospital clinicians
Andres, B. et al. [14]
[Conference abstract]
Suspected allergy to beta-lactam antibiotic:
The value of diagnostic evaluation
Spain, Allergy
Department 2013 Telephone survey
To assess the number of patients
with confirmed beta-lactam allergy,
drugs involved in reactions, and the
usefulness of the diagnostic tests
40 patients who had a negative
penicillin allergy test
Blumenthal, K.G. et al. [15]
Effect of a drug allergy educational program
and antibiotic prescribing guideline on
inpatient clinical providers’ antibiotic
prescribing knowledge
U.S., tertiary care
facility 2014 Questionnaire
To survey inpatient providers to
ascertain their baseline drug allergy
knowledge and preparedness in
caring for patients with
penicillin allergy
258 inpatient providers from
neurology, paediatrics, internal
medicine, orthopaedic surgery,
general surgery, attending hospital
physicians, and nurse practitioners
Cohen, S. et al. [16]
[Conference abstract]
The real use of beta-lactams after “penicillin
allergic” label removal Israel, allergy clinic 2012
Telephone
questionnaire
To assess patients’ confidence in
their allergy test results and whether
they have taken penicillin
since testing
106 patients who had a negative
penicillin allergy test
Elkhalifa, S. et al. [17]
[Conference abstract]
Management of patients with a history of
penicillin allergy: Barriers to best practice and
strategies to overcome them
U.K., general hospital 2017 Email survey
To investigate prescribers’
knowledge of penicillin allergy
diagnosis and management and
their views about the barriers to
correct management
164 hospital doctors including
doctors in training, consultants,
and non-medical prescribers
Eriksson, M. et al. [18]
[Conference abstract]
Are patients prone to using penicillin after
testing negative for penicillin allergy at
a specialist centre?
Sweden, allergy clinic 2017 Questionnaire
To assess, if tested negatively for
penicillin allergy, patients’ attitude
to future penicillin treatment
103 patients who had a negative
penicillin allergy test
Gerace, K. & Phillips, E. [19] Penicillin allergy label persists despitenegative testing U.S., allergy clinic 2015
Email or telephone
survey
To elucidate patient interpretation of
their results and antibiotic utilisation
after penicillin allergy testing (PAT)
42 patients who underwent PAT
Grillo, J. A. & Le, T.V. [20]
[Conference abstract]
An assessment of current practice and
knowledge of penicillin allergy at
hospital-based paediatric centres
U.S., hospital-based
centres 2015 Online survey
To assess current knowledge of
clinicians and management of
penicillin allergy
Inpatient paediatric providers at
hospital-based centres
Hayoun, M.B. et al. [21]
The impact of allergy to beta-lactam
antibiotics on general practitioners and
patients in a cohort of 154 French patients
France, primary care 2015 Telephonequestionnaire
To evaluate the role of the general
practitioner (GP) in the management
of allergy to Beta Lactams, and to
analyse the interpretation of the
allergological assessment by the GPs
or patients themselves
80 GPs and 26 patients (when GP
not available)
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Table 1. Cont.
Authors Title Country, Setting Year Design Research Aim Population
Jose, J. & Ishmael, F. T. [22]
[Conference abstract]
A drug allergy education handout is an easy
and effective method to improve patient
awareness of penicillin allergy and increase
penicillin testing
U.S., allergy clinic 2017 Survey
To assess patients’ prior knowledge
of penicillin allergy and whether
they were interested in being
allergy tested
67 patients who attended a general
allergy clinic
Phillips, E. J. et al. [23]
[Conference abstract]
The Utility of Penicillin Skin Testing in
a Tertiary Care Clinic
Canada, Drug Safety
Clinic 2002 Telephone survey
To determine how the information
provided from penicillin skin testing
affects beta-lactam antibiotic use or
patient attitudes towards future use
of beta-lactam antibiotics
348 patients who had a negative
penicillin allergy test
Picard, M. et al. [24]
Treatment of Patients with a History of
Penicillin Allergy in a Large Tertiary-Care
Academic Hospital
Canada, general
hospital 2013 Survey
To assess allergy referral habits for
patients with a history of
penicillin allergy
44 attending physicians
Ratzon, R. et al., [25]
Impact of an extended challenge on the
effectiveness of beta-lactam
hypersensitivity investigation
Israel, medical centre 2016 Survey
To evaluate the effectiveness of
a 7-day Drug Provocation Test (DPT)
and a 1-day (short) DPT for
beta-lactam allergy
49 patients who had a negative
penicillin allergy test
Semedo, F.M. [26]
[Conference abstract]
Full course drug provocation tests to
penicillins—do we really need them? Portugal, not known 2017 Survey
To evaluate diagnosis of
penicillin allergy
54 patients who had a negative
penicillin allergy test
Soni, D. et al. [27]
[Conference abstract]
A clinical perspective: the prescribers’ true
understanding of the
penicillin-allergic patient
U.S., not known 2016 Survey
To survey knowledge of inpatient
providers from different specialties
regarding penicillin allergy
121 inpatients providers
Staicu, M.L. et al. [28]
A survey of inpatient practitioner knowledge
of penicillin allergy at 2 community
teaching hospitals
U.S.,
community-based
teaching hospitals
2017 Online survey
To describe health care practitioner
behaviour and identify potential
knowledge gaps pertinent to the
management of the
penicillin-allergic patient
276 healthcare practitioners
including attending physicians,
advanced practice practitioners,
pharmacists, and residents
Suetrong, N. &
Klaewsongkram, J. [29]
The Differences and Similarities between
Allergists and Non-Allergists for Penicillin
Allergy Management
Thailand 2014 Email survey
To assess knowledge of penicillin
allergy skin testing and attitudes
towards the management of patients
with a history of penicillin allergy
205 physicians including general
practitioners, internists,
paediatricians, allergists
Sundquist, B. K. et al. [30]
Proactive penicillin allergy testing in primary
care patients labelled as allergic: outcomes
and barriers
U.S., academic
Internal Medicine
practice
2017
Telephone survey
(patients); Online
survey (general
practitioners)
To determine patient satisfaction
with PAT to determine barriers to
referring patients to testing
31 patients who had a negative
penicillin allergy test
7 primary care clinicians who
referred patients to the study
Trubiano, J. A. [31]
Improving Antimicrobial Stewardship by
Antibiotic Allergy Delabelling: Evaluation of
Knowledge, Attitude, and Practices
Throughout the Emerging Infections Network
U.S. and Canada,
the Emerging
Infections Network
2016 Email survey
To assess receptiveness for
incorporating antibiotic allergy
testing in hospitals
736 active members of the
Emerging Infections Network
clinicians: Adult and paediatric
Infectious Disease physicians
Warrington, R. J. et al. [32]
The value of skin testing for penicillin allergy
in an inpatient population: analysis of the
subsequent patient management.
Canada, allergy clinic 2000 Telephone survey
To assess why antibiotics were not
taken after a negative skin test for
penicillin allergy
84 patients who had a negative
penicillin allergy skin test
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3.1. Clinicians’ Views of Penicillin Allergy Testing
Six studies investigated clinicians’ referral rates for PAT as well as their views of the referral
process. These included both primary and secondary care providers.
The referral rates reported by healthcare professionals were generally low. Picard et al. reported
very low referral rates among clinicians in a Canadian hospital, where only 16% of clinicians had
ever referred a patient to an allergist [24]. In a U.S. study, Sundquist and colleagues found that in
a six-month period, primary care practitioners asked only 50% of eligible patients if they would like
to attend PAT [30]. Two additional studies identified similar findings: Soni et al. found that more
than 80% of general internal medicine practitioners in one U.S. health centre had never consulted an
allergy service [27], whilst Elkhalifa et al. found that over 60% of health care professionals in a U.K.
hospital had not referred to an allergy service in the past year [17]. Hayoun et al. asked French primary
care practitioners who had referred patients for penicillin allergy testing what criteria they use for
referring patients [21]. Over half reported no particular criteria for referring patients, and those who
mentioned referral criteria reported various factors, thus suggesting a lack of a uniform approach.
Reported criteria included initial severe reaction to beta-lactams, young age, and lack of alternative
treatment options [21]. The criteria used to exclude patients from a diagnostic assessment were older
age and reaction after eight days or maculopapular rash. Picard et al. also reported that one of the
main barriers for clinicians to referring patients was not knowing indications for referral [24] while
Soni et al. found that only 20% of clinicians were able to correctly identify appropriate patients for
penicillin allergy skin testing [27].
Three studies focused specifically on barriers and facilitators to the referral. Sundquist et al.
investigated views of primary care clinicians on referring patients to an allergy clinic. They were
asked to indicate the degree to which possible barriers might prevent them from referring patients:
the greatest perceived barrier was that patients may not want to get tested, followed by the time
required for discussing testing in consultations; anticipation that patients would not want to risk
having a reaction; forgetting to discuss testing; and physicians not being aware that patients had
an allergy [30]. In a second study, Picard et al. reported that lack of allergy testing services in
Canada was a major barrier to referral [24]. In addition, Trubiano et al. investigated views of adult
and paediatric infectious disease physicians and found that 23% of respondents did not have access
to any form of allergy testing whereas only 27% had access to skin testing combined with an oral
challenge [31]. Also, 40% were unaware of the specific nature of available testing. In the same study,
most respondents reported that it was worthwhile to refer patients for testing (93%), and they believed
testing would lead to removing the antibiotic allergy label (78%). They also believed that potential
benefits of removing antibiotic allergy label included better antibiotic selection, improved antibiotic
appropriateness, and safety of antibiotic administration [31].
Lastly, Elkhalifa et al. highlighted difficulties for health care professionals in assessing allergy and
reported that over 55% of clinicians thought that it was often impossible to draw conclusions based on
history alone, especially given time constraints [17].
An additional five studies investigated practitioners’ views and knowledge of penicillin
allergy, and found that health care professionals often had a limited knowledge of drug allergies.
The studies reported that many healthcare professionals had misconceptions about the nature
of allergy with four studies showing that 39–57% of hospital providers believed that allergy is
permanent [13,15,20,27,28]. Amin et al. found that in a survey of hospital doctors, 63% of healthcare
professionals were aware of true penicillin allergy reaction signs and symptoms, 23% had considered
antibiotic side effects as an allergic reaction, and 13% were unaware of the characteristics of an allergic
reaction [13]. Similarly, Blumenthal, who reported on knowledge levels of inpatient providers in
a tertiary medical centre in the U.S., found that knowledge about penicillin skin testing was poor,
with only 36% of providers knowing that skin testing is a valid tool for assessing penicillin allergy.
In a study involving paediatric hospital providers, Grillo and Le reported that even fewer clinicians
(21%) thought skin testing was a reliable tool for assessing pen-allergy [20]. Lastly, Amin et al. and
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Elkhalifa et al. highlighted that secondary care providers received little or no training in drug allergy
and that they felt unprepared to deal with these allergies [13,17].
3.2. Patients’ Views of Penicillin Allergy Testing
Only two studies explored patients’ views and satisfaction with PAT. Sundquist and colleagues
sought patients’ views following a three-step testing procedure consisting of skin prick testing,
intradermal testing (IDT), and oral challenge (OC). These patients were referred by their primary
care clinicians to a U.S. allergy clinic. They found that all patients felt that PAT provided valuable
medical information [30]. However, this was measured using a single-item questionnaire (“Do you
think undergoing testing for penicillin allergy provides important information for your penicillin
history?”). Jose and Ishmael assessed patients’ views about hypothetical penicillin testing [22]. A small
sample of patients attending a general allergy clinic in the U.S. were given a brief, 5-question survey to
assess their knowledge and views of pen-allergy testing. The majority of respondents were unaware
that drug allergy can wane over time, and they had not been informed by their primary care provider
about the availability of PAT but all expressed an interest in testing [22].
3.3. Influences on Clinician Antibiotic Prescribing Behaviour when Treating Patients with Suspected
Penicillin Allergy
Only two studies investigated influences on clinicians’ antibiotic prescribing behaviour in relation
to penicillin allergy. Elkhalifa et al. found that almost 60% of consultants and doctors in training agreed
that it is always better to “play it safe” and not use beta-lactams in patients labelled penicillin-allergic [13].
Interestingly, the majority did not agree with a statement that penicillin allergy is not important “as there
are many alternative antibiotics to beta-lactams that have comparable efficacy and safety” [17]. However,
Suetrong and Klaewsongkram surveyed Thai physicians and found that one of the major factors influencing
prescribing behaviour was the ready availability of alternative antibiotics [29].
3.4. Influences on Clinician Antibiotic Prescribing Behaviour and Patient Antibiotic Use Following a Penicllin
Allergy Test
Seven studies measured patient consumption of penicillins following a negative allergy test. Between 7%
and 41% of patients continued to avoid penicillins following a negative test [12,16,18,19,23,25,26].
Studies investigated reasons for not taking medication after testing. However, investigators
usually simply ascertained whether it was a patient who was reluctant to take penicillin or a clinician
who was reluctant to prescribe the drug. While Eriksson et al. reported that it was mainly patients
who were reluctant to take the drug [18], other studies reported that both patients were reluctant to
take and general practitioners (GPs) were reluctant to prescribe penicillin [12,16,19,21,25]. Phillips and
Gerace found that almost 50% of patients who reported continued avoidance of penicillin said that
they would tell a new provider that they were allergic [19].
Eight studies investigated these reasons in more detail. One of the most commonly reported
reasons among both patients and clinicians was fear of a further reaction, uncertainty about the severity
of such a reaction, and lack of confidence that penicillin could be safely administered [12,14,18,23,32].
Eriksson et al. reported that patients were unsure which type of antibiotics they could use safely [18].
Gerace and Phillips found similar gaps in patients’ knowledge following a negative result. Although all
patients were able to correctly identify whether skin testing had been positive or negative, patients who
had had a negative result were often unsure which antibiotic class (penicillin and/or cephalosporins
and/or all beta-lactams) they were now able to take [19]. Additional studies also reported that patients
avoided penicillins either because of lack of confidence in the test results [14,16,23,26] or distrust of
health care professionals’ advice [23]. Philips et al. reported that only 10% of patients felt that their
primary care physician positively influenced their willingness to take beta-lactams after a negative
allergy test [23]. Complementary to this, Suetrong and Klaewsongkram highlighted that only 5% of
inpatient medical providers knew how to correctly interpret penicillin skin test results [29].
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Finally, two studies investigated whether the type of allergy testing may affect patients’ confidence
in the results. Erikson found that there was no difference in concerns between those who were
investigated through skin test or through oral provocation test [18], and Ratzon found that while
100% of patients who tested negative by an extended drug provocation test (DPT) and later needed
a beta-lactam used it, only 76% of patients who underwent short DPT actually took the drug when
prescribed [25].
4. Discussion
This review provides an overview of the existing research in relation to patients’ and clinicians’
views of PAT and associated influences on antibiotic prescribing behaviour and penicillin use in the
context of penicillin allergy.
There was limited evidence on patients’ views of PAT. Although it was found that patients
valued the diagnostic information that tests provided, some thought it was a time-consuming process.
Clinicians reported a number of barriers to referral which were related to occupational pressures,
difficulties around taking allergy history, and their lack of knowledge about referral criteria as well as
concerns about patient safety. Following a test, both patients and clinicians often remained reluctant
to take and prescribe penicillins. This seemed to be linked to their negative beliefs about the test,
including a lack of confidence in the test result, and fear of subsequent drug reactions.
The results suggest that discussing penicillin allergy and testing can be challenging for clinicians,
especially if they are unsure about referral criteria and lack motivation to challenge a patient’s drug
allergy status. None of the studies which focused on views of primary care clinicians mentioned
antimicrobial stewardship or adherence to clinical guidelines for PAT as a reason for referring
patients for PAT. This may be because the idea that PAT is a potentially important antimicrobial
stewardship activity is relatively new and has not been well publicised in primary care. It is also
possible that antimicrobial stewardship does not act as a sufficient motivator to change their behavior.
The results also highlight that referring or attending for the test is not sufficient for both a patient
and primary care clinician to accept the test result and prescribe/take penicillin following a negative
test. Clinicians may require further information including the clinical meaning of a test result and
its implications. Patient education could also include information about the test process and the
potential benefits of being able to take penicillins. This could improve the patient’s confidence in
the test results and their willingness to take the drug, should it be prescribed for them. However,
this will only be possible if clinicians have adequate knowledge and understanding of allergies and
testing. Both primary and secondary care professionals are likely to benefit from further training about
penicillin allergy and testing, including its accuracy, implications, and benefits, in order to be able to
discuss these issues with patients.
Changing both patients’ and GPs’ views about PAT and subsequent medication adherence is
very important as it is in line with one of the key aims of antibiotic stewardship, as outlined in the
U.K. five-year antimicrobial resistance (AMR) strategy to “conserve and steward the effectiveness of
existing treatments” [33]. Penicillins are an important group of antibiotics and remain first-line therapy
for many common infections but a record of penicillin allergy has significant effects for antimicrobial
prescribing. Removing inappropriate penicillin allergy labels can help patients to receive first-line
treatments for infections, suffer lesser side effects, and recover quicker [3,34,35]. It will also help
in tacking antimicrobial resistance by substituting broad-spectrum antibiotics, which these patients
normally receive, with narrow-spectrum penicillin.
Limitations
The rapid review identified only studies which used a cross-sectional survey design to explore
clinician and patient views, with the majority focusing on clinical aspects of penicillin allergy tests and
their accuracy. No qualitative studies were identified. Therefore, exploring patients’ and clinicians’
motivations and beliefs was often only a secondary aim for most of the studies. As a result, the studies
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provided limited insight into patients’ and clinicians’ behaviour. This highlights the need for qualitative
studies to understand these complex behaviours. As this was a rapid review, it is possible that with
more time and resources a full systematic review could have found more studies using grey literature
searches and including non-English-language reports. It is also possible that lack of quality assessment
and lack of double-checking abstracts and full texts could have introduced a bias.
A limited number of studies explored clinicians’ reasons for not wanting to prescribe penicillins
following a negative test. Most evidence came from studies with patients who reported their
perspectives on their clinician’s difficulties in prescribing, rather than directly asking clinicians
themselves. Subsequently, results should be interpreted with caution.
5. Conclusions
The existing literature highlights a number of challenges to successful implementation of PAT.
Both patients and clinicians need to be supported to use PAT services and equipped with the skills to
prescribe and consume penicillins appropriately following a negative test result.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6382/7/3/71/s1.
Search Strategies.
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